Literature DB >> 15951102

Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations.

E Nieschlag1, R Swerdloff, H M Behre, L J Gooren, J M Kaufman, J-J Legros, B Lunenfeld, J E Morley, C Schulman, C Wang, W Weidner, F C W Wu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15951102     DOI： 10.1016/j.eururo.2005.04.027

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  33 in total

Review 1.  Mild cognitive impairment and dementia: the importance of modifiable risk factors.

Authors:  Thorleif Etgen; Dirk Sander; Horst Bickel; Hans Förstl
Journal:  Dtsch Arztebl Int       Date:  2011-11-04       Impact factor: 5.594

Review 2.  The treatment of late-onset hypogonadism.

Authors:  Oktay Üçer; Bilal Gümüş
Journal:  Turk J Urol       Date:  2014-03-24

3.  Occurrence of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome in patients with abdominal obesity. Where is a sufficient level of testosterone?

Authors:  Juraj Fillo; Jan Breza; Michaela Levčíkova; Jan Luha; Anna Vachulova; Štefan Durdík; Peter Labaš
Journal:  Int Urol Nephrol       Date:  2012-08       Impact factor: 2.370

4.  Vascular risk factors and their association to serum androgen levels in a population-based cohort of 75-year-old men over 5 years: results of the VITA study.

Authors:  Anton Ponholzer; Stephan Madersbacher; Michael Rauchenwald; Susanne Jungwirth; Peter Fischer; Karl-Heinz Tragl
Journal:  World J Urol       Date:  2009-06-28       Impact factor: 4.226

Review 5.  Male sexual dysfunction in Asia.

Authors:  Christopher Ck Ho; Praveen Singam; Goh Eng Hong; Zulkifli Md Zainuddin
Journal:  Asian J Androl       Date:  2011-06-06       Impact factor: 3.285

Review 6.  Androgens and male aging: Current evidence of safety and efficacy.

Authors:  Louis J Gooren
Journal:  Asian J Androl       Date:  2010-02-15       Impact factor: 3.285

7.  Synergetic effect of testosterone and phophodiesterase-5 inhibitors in hypogonadal men with erectile dysfunction: A systematic review.

Authors:  Naif Alhathal; Ahmed M Elshal; Serge Carrier
Journal:  Can Urol Assoc J       Date:  2012-08       Impact factor: 1.862

8.  [Testosterone and psyche].

Authors:  C Leiber; U Wetterauer; M Berner
Journal:  Urologe A       Date:  2010-01       Impact factor: 0.639

9.  The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2.

Authors:  Farid Saad; Louis J Gooren
Journal:  J Obes       Date:  2010-08-10

10.  Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations.

Authors:  C Wang; E Nieschlag; R Swerdloff; H M Behre; W J Hellstrom; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; A Morales; J E Morley; C Schulman; I M Thompson; W Weidner; F C W Wu
Journal:  Eur J Endocrinol       Date:  2008-11       Impact factor: 6.664
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.